FIELD: medicine.
SUBSTANCE: invention refers to medicine and aims at Barrett's oesophagus therapy. The method involves partial inhibition of Notch activation. Preferentially, a γ-secretase inhibitor is applied.
EFFECT: use of the group of inventions allows reducing pathological signs of Barrett's oesophagus observed in an animal at least partially.
9 cl, 3 ex, 6 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPY OF INTESTINAL ADENOMA AND/OR ADENOCARCINOMA BY INHIBITING NOTCH ACTIVATION | 2005 |
|
RU2392961C2 |
| CULTURE MEDIUM FOR STEM CELLS | 2012 |
|
RU2714256C2 |
| IMPROVED DIFFERENTIATION METHOD | 2017 |
|
RU2772435C2 |
| LIVER ORGANOID, VERSIONS OF USE THEREOF AND CULTURE METHOD FOR PRODUCTION THEREOF | 2011 |
|
RU2579995C2 |
| CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS, CONTAINING THEREOF | 2010 |
|
RU2555545C2 |
| DOUBLE TUBULAR STRUCTURES | 2017 |
|
RU2756404C1 |
| INHIBITORS OF NOTCH SIGNAL TRANSMISSION WAYS AND THEIR APPLICATION FOR CANCER TREATMENT | 2012 |
|
RU2631611C2 |
| ANTIBODIES AGAINST NOTCH2 AND METHODS FOR APPLICATION THEREOF | 2009 |
|
RU2580029C2 |
| THERAPEUTIC METHODS OF VASCULAR EYE DISEASE TREATMENT WITH Dll4 ANTAGONISTS | 2007 |
|
RU2429876C2 |
| ANTIBODIES TO JAGGED AND METHODS OF THEIR USE | 2013 |
|
RU2666990C2 |
